Search research articles
Contact Us
Filters
Showing results (21-30 of 114) with videos related to
Page
of 12
Sort By:
Investigational New Drugs
|
May 10, 2006
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study
Robert P Whitehead, Sheryl McCoy, John S Macdonald, et al.
American Journal of Hematology
|
August 19, 2007
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)
Stephen H Petersdorf, Cathryn Rankin, David R Head, et al.
The Journal of Supportive Oncology
|
February 3, 2007
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma
Aminah Jatoi, Phuong L Nguyen, Nathan Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study
Quynh-Thu Le, Jason McCoy, Stephen Williamson, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial
Stephen K Williamson, Sheryl A McCoy, David R Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 29, 2013
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer
Hak Choy, Lee S Schwartzberg, Shaker R Dakhil, et al.
International Journal of Oncology
|
February 4, 2010
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials
Aminah Jatoi, Nathan R Foster, James R Egner, et al.
The Prostate
|
September 5, 2002
SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study
Catherine E Klein, Catherine M Tangen, Thomas J Braun, et al.
Therapeutic Advances in Medical Oncology
|
March 24, 2020
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
Hao Xie, Jacqueline M Lafky, Bruce W Morlan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 27, 2009
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8
Ann E Kearns, Donald W Northfelt, Amylou C Dueck, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 114) with videos related to
Sort By:
Page
of 12
Investigational New Drugs
|
May 10, 2006
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study
Robert P Whitehead, Sheryl McCoy, John S Macdonald, et al.
American Journal of Hematology
|
August 19, 2007
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)
Stephen H Petersdorf, Cathryn Rankin, David R Head, et al.
The Journal of Supportive Oncology
|
February 3, 2007
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma
Aminah Jatoi, Phuong L Nguyen, Nathan Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study
Quynh-Thu Le, Jason McCoy, Stephen Williamson, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial
Stephen K Williamson, Sheryl A McCoy, David R Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 29, 2013
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer
Hak Choy, Lee S Schwartzberg, Shaker R Dakhil, et al.
International Journal of Oncology
|
February 4, 2010
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials
Aminah Jatoi, Nathan R Foster, James R Egner, et al.
The Prostate
|
September 5, 2002
SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study
Catherine E Klein, Catherine M Tangen, Thomas J Braun, et al.
Therapeutic Advances in Medical Oncology
|
March 24, 2020
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
Hao Xie, Jacqueline M Lafky, Bruce W Morlan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 27, 2009
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8
Ann E Kearns, Donald W Northfelt, Amylou C Dueck, et al.
Page
of 12